{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:22:37Z","timestamp":1783009357629,"version":"3.54.5"},"reference-count":46,"publisher":"American Veterinary Medical Association (AVMA)","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"sc_a1\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the effects of dexmedetomidine (DEX) constant-rate infusion (CRI) on glucose tolerance and metabolic responses in healthy dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sc_a2\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a prospective, randomized, repeated-measures study, 5 healthy adult Beagles received 4 treatments: low-dose DEX (1 \u00b5g\/kg loading; 1 \u00b5g\/kg\/h CRI), medium-dose DEX (5 \u00b5g\/kg loading; 5 \u00b5g\/kg\/h CRI), high-dose DEX (10 \u00b5g\/kg loading; 10 \u00b5g\/kg\/h CRI), or saline. An IV glucose tolerance test was performed 30 minutes after CRI initiation. Serum glucose and insulin were measured. Data were analyzed using linear mixed-effects models, with treatment, time, and their interaction as fixed effects and dog as a random effect. Results are reported as effect sizes with 95% CIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sc_a3\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>DEX CRI suppressed insulin secretion in a dose-related manner during the early phase of the glucose tolerance test. Compared with control, glucose disappearance rate was reduced at medium (mean difference, \u22121.37%\/min; 95% CI, \u22122.32 to \u22120.42) and high (mean difference, \u22121.45%\/min; 95% CI, \u22122.36 to \u22120.54) infusion rates, whereas the low-dose treatment did not differ meaningfully (mean difference, \u22120.68%\/min; 95% CI, \u22121.63 to 0.27). No clinically relevant adverse events occurred.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sc_a4\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>DEX CRI causes dose-related suppression of insulin secretion and impairs glucose tolerance at medium and high infusion rates in healthy dogs. In contrast, the clinically used low infusion rate did not substantially alter glucose tolerance under study conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sc_a5\">\n                    <jats:title>Clinical Relevance<\/jats:title>\n                    <jats:p>Medium- and high-dose DEX CRI may impair glucose tolerance in healthy dogs, whereas the clinically used low-dose regimen appears unlikely to disrupt glucose homeostasis under controlled conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2460\/ajvr.25.12.0427","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:49:26Z","timestamp":1774529366000},"source":"Crossref","is-referenced-by-count":0,"title":["Dexmedetomidine constant-rate infusion suppresses insulin secretion and impairs glucose tolerance in healthy dogs"],"prefix":"10.2460","volume":"87","author":[{"given":"Kenichi","family":"Maeda","sequence":"first","affiliation":[{"name":"Department of Small Animal Surgery 2, School of Veterinary Medicine, Kitasato University, Towada, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misaki","family":"Inada","sequence":"additional","affiliation":[{"name":"Department of Small Animal Surgery 2, School of Veterinary Medicine, Kitasato University, Towada, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Iwai","sequence":"additional","affiliation":[{"name":"Department of Small Animal Surgery 2, School of Veterinary Medicine, Kitasato University, Towada, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Okano","sequence":"additional","affiliation":[{"name":"Department of Small Animal Surgery 2, School of Veterinary Medicine, Kitasato University, Towada, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"issue":"7","key":"B1","series-title":"Mayo Clin Proc","first-page":"862","article-title":"Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients","author":"Gandhi GY","year":"2005","unstructured":"Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005;80(7):862\u2013866. doi:10.4065\/80.7.862"},{"issue":"6","key":"B2","series-title":"Ann Surg","first-page":"845","article-title":"Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms","author":"Turina M","year":"2006","unstructured":"Turina M, Miller FN, Tucker CF, Polk HC. Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms. Ann Surg. 2006;243(6):845\u2013853. doi:10.1097\/01.sla.0000220041.68156.67"},{"issue":"1","key":"B3","series-title":"Ann Surg","first-page":"97","article-title":"Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes","author":"Kotagal M","year":"2015","unstructured":"Kotagal M, Symons RG, Hirsch IB, et al. Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg. 2015;261(1):97\u2013103. doi:10.1097\/SLA.0000000000000688"},{"issue":"4","key":"B4","series-title":"Vet Ophthalmol","first-page":"244","article-title":"A comparison of anesthetic complications between diabetic and nondiabetic dogs undergoing phacoemulsification cataract surgery: a retrospective study","author":"Oliver JAC","year":"2010","unstructured":"Oliver JAC, Clark L, Corletto F, Gould DJ. A comparison of anesthetic complications between diabetic and nondiabetic dogs undergoing phacoemulsification cataract surgery: a retrospective study. Vet Ophthalmol. 2010;13(4):244\u2013250. doi:10.1111\/j.1463-5224.2010.00793.x"},{"key":"B5","series-title":"Vet J","first-page":"33","article-title":"Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a glibenclamide-induced canine hypoglycaemia model","author":"Kallio-Kujala IJ","year":"2018","unstructured":"Kallio-Kujala IJ, Bennett RC, Raekallio MR, et al. Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a glibenclamide-induced canine hypoglycaemia model. Vet J. 2018;242:33\u201338. doi:10.1016\/j.tvjl.2018.09.012"},{"key":"B6","series-title":"Front Vet Sci","first-page":"1161002","article-title":"Low dose dexmedetomidine infusion for the management of hypoglycaemia in a dog with an insulinoma","author":"Green R","year":"2023","unstructured":"Green R, Musulin SE, Baja AJ, Hansen BD. Low dose dexmedetomidine infusion for the management of hypoglycaemia in a dog with an insulinoma. Front Vet Sci. 2023;10:1161002. doi:10.3389\/fvets.2023.1161002"},{"issue":"4","key":"B7","series-title":"FEBS Open Bio","first-page":"634","article-title":"Dexmedetomidine suppresses glucose-stimulated insulin secretion in pancreatic \u03b2-cells","author":"Kusunoki M","year":"2025","unstructured":"Kusunoki M, Hirota K, Shoji T, Uba T, Matsuo Y, Hayashi M. Dexmedetomidine suppresses glucose-stimulated insulin secretion in pancreatic \u03b2-cells. FEBS Open Bio. 2025;15(4):634\u2013646. doi:10.1002\/2211-5463.13960"},{"issue":"1","key":"B8","series-title":"Can J Vet Res","first-page":"42","article-title":"Neurohormonal and metabolic effects of medetomidine compared with xylazine in Beagle dogs","author":"Ambrisko TD","year":"2002","unstructured":"Ambrisko TD, Hikasa Y. Neurohormonal and metabolic effects of medetomidine compared with xylazine in Beagle dogs. Can J Vet Res. 2002;66(1):42\u201349."},{"issue":"1","key":"B9","series-title":"J Vet Pharmacol Ther","first-page":"15","article-title":"Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs","author":"Kuusela E","year":"2000","unstructured":"Kuusela E, Raekallio M, Anttila M, Falck I, M\u00f6ls\u00e4 S, Vainio O. Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs. J Vet Pharmacol Ther. 2000;23(1):15\u201320. doi:10.1046\/j.1365-2885.2000.00245.x"},{"key":"B10","series-title":"BMC Vet Res","first-page":"48","article-title":"A comparison of medetomidine and its active enantiomer dexmedetomidine when administered with ketamine in mice","author":"Burnside WM","year":"2013","unstructured":"Burnside WM, Flecknell PA, Cameron AI, Thomas AA. A comparison of medetomidine and its active enantiomer dexmedetomidine when administered with ketamine in mice. BMC Vet Res. 2013;9:48. doi:10.1186\/1746-6148-9-48"},{"issue":"4","key":"B11","series-title":"Vet Anaesth Analg","first-page":"369","article-title":"Clinical evaluation of the efficacy and safety of a constant rate infusion of dexmedetomidine for postoperative pain management in dogs","author":"Valtolina C","year":"2009","unstructured":"Valtolina C, Robben JH, Uilenreef J, et al. Clinical evaluation of the efficacy and safety of a constant rate infusion of dexmedetomidine for postoperative pain management in dogs. Vet Anaesth Analg. 2009;36(4):369\u2013383. doi:10.1111\/j.1467-2995.2009.00461.x"},{"key":"B12","series-title":"Front Vet Sci","first-page":"1061605","article-title":"Evaluation of a constant rate intravenous infusion of dexmedetomidine on the duration of a femoral and sciatic nerve block using lidocaine in dogs","author":"Stabile M","year":"2023","unstructured":"Stabile M, Lacitignola L, Acquafredda C, Scardia A, Crovace A, Staffieri F. Evaluation of a constant rate intravenous infusion of dexmedetomidine on the duration of a femoral and sciatic nerve block using lidocaine in dogs. Front Vet Sci. 2023;9:1061605. doi:10.3389\/fvets.2022.1061605"},{"issue":"1","key":"B13","series-title":"Br J Anaesth","first-page":"109","article-title":"The stress response to trauma and surgery","author":"Desborough JP","year":"2000","unstructured":"Desborough JP. The stress response to trauma and surgery. Br J Anaesth. 2000;85(1):109\u2013117. doi:10.1093\/bja\/85.1.109"},{"issue":"1\u20133","key":"B14","series-title":"Eur J Pharmacol","first-page":"243","article-title":"Altered glucose homeostasis in \u03b12A adrenoceptor knockout mice","author":"Fagerholm V","year":"2004","unstructured":"Fagerholm V, Gr\u00f6nroos T, Marjam\u00e4ki P, Viljanen T, Scheinin M, Haaparanta M. Altered glucose homeostasis in \u03b12A adrenoceptor knockout mice. Eur J Pharmacol. 2004;505(1\u20133):243\u2013252. doi:10.1016\/j.ejphar.2004.10.023"},{"issue":"4","key":"B15","series-title":"J Feline Med Surg","first-page":"344","article-title":"Effects of dexmedetomidine on glucose homeostasis in healthy cats","author":"Bouillon J","year":"2020","unstructured":"Bouillon J, Duke T, Focken AP, Snead EC, Cosford KL. Effects of dexmedetomidine on glucose homeostasis in healthy cats. J Feline Med Surg. 2020;22(4):344\u2013349. doi:10.1177\/1098612X19847282"},{"issue":"2","key":"B16","series-title":"Vet Sci","first-page":"43","article-title":"Effect of propofol continuous-rate infusion on intravenous glucose tolerance test in dogs","author":"Maeda K","year":"2018","unstructured":"Maeda K, Iwasaki M, Itou Y, Iwai S, Okano S. Effect of propofol continuous-rate infusion on intravenous glucose tolerance test in dogs. Vet Sci. 2018;5(2):43. doi:10.3390\/vetsci5020043"},{"issue":"6","key":"B17","series-title":"J Vet Med Sci","first-page":"929","article-title":"The pharmacological effects of intramuscular administration of alfaxalone combined with medetomidine and butorphanol in dogs","author":"Tamura J","year":"2016","unstructured":"Tamura J, Hatakeyama N, Ishizuka T, et al. The pharmacological effects of intramuscular administration of alfaxalone combined with medetomidine and butorphanol in dogs. J Vet Med Sci. 2016;78(6):929\u2013936. doi:10.1292\/jvms.15-0159"},{"issue":"2","key":"B18","series-title":"Vet Anaesth Analg","first-page":"174","article-title":"Use of intravenous lidocaine to treat dexmedetomidine-induced bradycardia in sedated and anesthetized dogs","author":"Tisotti T","year":"2021","unstructured":"Tisotti T, Valverde A, Hopkins A, O\u2019Sullivan ML, Hanna B, Arroyo L. Use of intravenous lidocaine to treat dexmedetomidine-induced bradycardia in sedated and anesthetized dogs. Vet Anaesth Analg. 2021;48(2):174\u2013186. doi:10.1016\/j.vaa.2020.11.005"},{"issue":"15","key":"B19","series-title":"Animals","first-page":"2274","article-title":"Clinical effects and pharmacokinetic profile of intramuscular dexmedetomidine (10 \u00b5g\/kg) in cats","author":"Fernandes NS","year":"2024","unstructured":"Fernandes NS, Passos YDB, Arcoverde KN, et al. Clinical effects and pharmacokinetic profile of intramuscular dexmedetomidine (10 \u00b5g\/kg) in cats. Animals. 2024;14(15):2274. doi:10.3390\/ani14152274"},{"issue":"4","key":"B20","series-title":"Vet Anaesth Analg","first-page":"360","article-title":"The cardiopulmonary effects of dexmedetomidine infusions in dogs during isoflurane anesthesia","author":"Pascoe PJ","year":"2015","unstructured":"Pascoe PJ. The cardiopulmonary effects of dexmedetomidine infusions in dogs during isoflurane anesthesia. Vet Anaesth Analg. 2015;42(4):360\u2013368. doi:10.1111\/vaa.12220"},{"issue":"6","key":"B21","series-title":"Animals","first-page":"892","article-title":"Impact of a dexmedetomidine intravenous infusion in septic dogs: preliminary study","author":"Di Franco C","year":"2024","unstructured":"Di Franco C, Boysen S, Vannozzi I, Briganti A. Impact of a dexmedetomidine intravenous infusion in septic dogs: preliminary study. Animals. 2024;14(6):892. doi:10.3390\/ani14060892"},{"issue":"1","key":"B22","series-title":"Diabetes Metab J","first-page":"1","article-title":"AMPK and exercise: glucose uptake and insulin sensitivity","author":"O\u2019Neill HM","year":"2013","unstructured":"O\u2019Neill HM. AMPK and exercise: glucose uptake and insulin sensitivity. Diabetes Metab J. 2013;37(1):1\u201321. doi:10.4093\/dmj.2013.37.1.1"},{"issue":"4","key":"B23","series-title":"Rev Bras Anestesiol","first-page":"429","article-title":"Effects of dexmedetomidine on renal system and on vasopressin plasma levels: experimental study in dogs","author":"Villela NR","year":"2005","unstructured":"Villela NR, Nascimento MP, de Carvalho LR, Teixeira VC. Effects of dexmedetomidine on renal system and on vasopressin plasma levels: experimental study in dogs. Rev Bras Anestesiol. 2005;55(4):429\u2013440. doi:10.1590\/s0034-70942005000400007"},{"issue":"7","key":"B1","series-title":"Mayo Clin Proc","first-page":"862","article-title":"Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients","author":"Gandhi GY","year":"2005","unstructured":"Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005;80(7):862\u2013866. doi:10.4065\/80.7.862"},{"issue":"6","key":"B2","series-title":"Ann Surg","first-page":"845","article-title":"Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms","author":"Turina M","year":"2006","unstructured":"Turina M, Miller FN, Tucker CF, Polk HC. Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms. Ann Surg. 2006;243(6):845\u2013853. doi:10.1097\/01.sla.0000220041.68156.67"},{"issue":"1","key":"B3","series-title":"Ann Surg","first-page":"97","article-title":"Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes","author":"Kotagal M","year":"2015","unstructured":"Kotagal M, Symons RG, Hirsch IB, et al. Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg. 2015;261(1):97\u2013103. doi:10.1097\/SLA.0000000000000688"},{"issue":"4","key":"B4","series-title":"Vet Ophthalmol","first-page":"244","article-title":"A comparison of anesthetic complications between diabetic and nondiabetic dogs undergoing phacoemulsification cataract surgery: a retrospective study","author":"Oliver JAC","year":"2010","unstructured":"Oliver JAC, Clark L, Corletto F, Gould DJ. A comparison of anesthetic complications between diabetic and nondiabetic dogs undergoing phacoemulsification cataract surgery: a retrospective study. Vet Ophthalmol. 2010;13(4):244\u2013250. doi:10.1111\/j.1463-5224.2010.00793.x"},{"key":"B5","series-title":"Vet J","first-page":"33","article-title":"Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a glibenclamide-induced canine hypoglycaemia model","author":"Kallio-Kujala IJ","year":"2018","unstructured":"Kallio-Kujala IJ, Bennett RC, Raekallio MR, et al. Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a glibenclamide-induced canine hypoglycaemia model. Vet J. 2018;242:33\u201338. doi:10.1016\/j.tvjl.2018.09.012"},{"key":"B6","series-title":"Front Vet Sci","first-page":"1161002","article-title":"Low dose dexmedetomidine infusion for the management of hypoglycaemia in a dog with an insulinoma","author":"Green R","year":"2023","unstructured":"Green R, Musulin SE, Baja AJ, Hansen BD. Low dose dexmedetomidine infusion for the management of hypoglycaemia in a dog with an insulinoma. Front Vet Sci. 2023;10:1161002. doi:10.3389\/fvets.2023.1161002"},{"issue":"4","key":"B7","series-title":"FEBS Open Bio","first-page":"634","article-title":"Dexmedetomidine suppresses glucose-stimulated insulin secretion in pancreatic \u03b2-cells","author":"Kusunoki M","year":"2025","unstructured":"Kusunoki M, Hirota K, Shoji T, Uba T, Matsuo Y, Hayashi M. Dexmedetomidine suppresses glucose-stimulated insulin secretion in pancreatic \u03b2-cells. FEBS Open Bio. 2025;15(4):634\u2013646. doi:10.1002\/2211-5463.13960"},{"issue":"1","key":"B8","series-title":"Can J Vet Res","first-page":"42","article-title":"Neurohormonal and metabolic effects of medetomidine compared with xylazine in Beagle dogs","author":"Ambrisko TD","year":"2002","unstructured":"Ambrisko TD, Hikasa Y. Neurohormonal and metabolic effects of medetomidine compared with xylazine in Beagle dogs. Can J Vet Res. 2002;66(1):42\u201349."},{"issue":"1","key":"B9","series-title":"J Vet Pharmacol Ther","first-page":"15","article-title":"Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs","author":"Kuusela E","year":"2000","unstructured":"Kuusela E, Raekallio M, Anttila M, Falck I, M\u00f6ls\u00e4 S, Vainio O. Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs. J Vet Pharmacol Ther. 2000;23(1):15\u201320. doi:10.1046\/j.1365-2885.2000.00245.x"},{"key":"B10","series-title":"BMC Vet Res","first-page":"48","article-title":"A comparison of medetomidine and its active enantiomer dexmedetomidine when administered with ketamine in mice","author":"Burnside WM","year":"2013","unstructured":"Burnside WM, Flecknell PA, Cameron AI, Thomas AA. A comparison of medetomidine and its active enantiomer dexmedetomidine when administered with ketamine in mice. BMC Vet Res. 2013;9:48. doi:10.1186\/1746-6148-9-48"},{"issue":"4","key":"B11","series-title":"Vet Anaesth Analg","first-page":"369","article-title":"Clinical evaluation of the efficacy and safety of a constant rate infusion of dexmedetomidine for postoperative pain management in dogs","author":"Valtolina C","year":"2009","unstructured":"Valtolina C, Robben JH, Uilenreef J, et al. Clinical evaluation of the efficacy and safety of a constant rate infusion of dexmedetomidine for postoperative pain management in dogs. Vet Anaesth Analg. 2009;36(4):369\u2013383. doi:10.1111\/j.1467-2995.2009.00461.x"},{"key":"B12","series-title":"Front Vet Sci","first-page":"1061605","article-title":"Evaluation of a constant rate intravenous infusion of dexmedetomidine on the duration of a femoral and sciatic nerve block using lidocaine in dogs","author":"Stabile M","year":"2023","unstructured":"Stabile M, Lacitignola L, Acquafredda C, Scardia A, Crovace A, Staffieri F. Evaluation of a constant rate intravenous infusion of dexmedetomidine on the duration of a femoral and sciatic nerve block using lidocaine in dogs. Front Vet Sci. 2023;9:1061605. doi:10.3389\/fvets.2022.1061605"},{"issue":"1","key":"B13","series-title":"Br J Anaesth","first-page":"109","article-title":"The stress response to trauma and surgery","author":"Desborough JP","year":"2000","unstructured":"Desborough JP. The stress response to trauma and surgery. Br J Anaesth. 2000;85(1):109\u2013117. doi:10.1093\/bja\/85.1.109"},{"issue":"1\u20133","key":"B14","series-title":"Eur J Pharmacol","first-page":"243","article-title":"Altered glucose homeostasis in \u03b12A adrenoceptor knockout mice","author":"Fagerholm V","year":"2004","unstructured":"Fagerholm V, Gr\u00f6nroos T, Marjam\u00e4ki P, Viljanen T, Scheinin M, Haaparanta M. Altered glucose homeostasis in \u03b12A adrenoceptor knockout mice. Eur J Pharmacol. 2004;505(1\u20133):243\u2013252. doi:10.1016\/j.ejphar.2004.10.023"},{"issue":"4","key":"B15","series-title":"J Feline Med Surg","first-page":"344","article-title":"Effects of dexmedetomidine on glucose homeostasis in healthy cats","author":"Bouillon J","year":"2020","unstructured":"Bouillon J, Duke T, Focken AP, Snead EC, Cosford KL. Effects of dexmedetomidine on glucose homeostasis in healthy cats. J Feline Med Surg. 2020;22(4):344\u2013349. doi:10.1177\/1098612X19847282"},{"issue":"2","key":"B16","series-title":"Vet Sci","first-page":"43","article-title":"Effect of propofol continuous-rate infusion on intravenous glucose tolerance test in dogs","author":"Maeda K","year":"2018","unstructured":"Maeda K, Iwasaki M, Itou Y, Iwai S, Okano S. Effect of propofol continuous-rate infusion on intravenous glucose tolerance test in dogs. Vet Sci. 2018;5(2):43. doi:10.3390\/vetsci5020043"},{"issue":"6","key":"B17","series-title":"J Vet Med Sci","first-page":"929","article-title":"The pharmacological effects of intramuscular administration of alfaxalone combined with medetomidine and butorphanol in dogs","author":"Tamura J","year":"2016","unstructured":"Tamura J, Hatakeyama N, Ishizuka T, et al. The pharmacological effects of intramuscular administration of alfaxalone combined with medetomidine and butorphanol in dogs. J Vet Med Sci. 2016;78(6):929\u2013936. doi:10.1292\/jvms.15-0159"},{"issue":"2","key":"B18","series-title":"Vet Anaesth Analg","first-page":"174","article-title":"Use of intravenous lidocaine to treat dexmedetomidine-induced bradycardia in sedated and anesthetized dogs","author":"Tisotti T","year":"2021","unstructured":"Tisotti T, Valverde A, Hopkins A, O\u2019Sullivan ML, Hanna B, Arroyo L. Use of intravenous lidocaine to treat dexmedetomidine-induced bradycardia in sedated and anesthetized dogs. Vet Anaesth Analg. 2021;48(2):174\u2013186. doi:10.1016\/j.vaa.2020.11.005"},{"issue":"15","key":"B19","series-title":"Animals","first-page":"2274","article-title":"Clinical effects and pharmacokinetic profile of intramuscular dexmedetomidine (10 \u00b5g\/kg) in cats","author":"Fernandes NS","year":"2024","unstructured":"Fernandes NS, Passos YDB, Arcoverde KN, et al. Clinical effects and pharmacokinetic profile of intramuscular dexmedetomidine (10 \u00b5g\/kg) in cats. Animals. 2024;14(15):2274. doi:10.3390\/ani14152274"},{"issue":"4","key":"B20","series-title":"Vet Anaesth Analg","first-page":"360","article-title":"The cardiopulmonary effects of dexmedetomidine infusions in dogs during isoflurane anesthesia","author":"Pascoe PJ","year":"2015","unstructured":"Pascoe PJ. The cardiopulmonary effects of dexmedetomidine infusions in dogs during isoflurane anesthesia. Vet Anaesth Analg. 2015;42(4):360\u2013368. doi:10.1111\/vaa.12220"},{"issue":"6","key":"B21","series-title":"Animals","first-page":"892","article-title":"Impact of a dexmedetomidine intravenous infusion in septic dogs: preliminary study","author":"Di Franco C","year":"2024","unstructured":"Di Franco C, Boysen S, Vannozzi I, Briganti A. Impact of a dexmedetomidine intravenous infusion in septic dogs: preliminary study. Animals. 2024;14(6):892. doi:10.3390\/ani14060892"},{"issue":"1","key":"B22","series-title":"Diabetes Metab J","first-page":"1","article-title":"AMPK and exercise: glucose uptake and insulin sensitivity","author":"O\u2019Neill HM","year":"2013","unstructured":"O\u2019Neill HM. AMPK and exercise: glucose uptake and insulin sensitivity. Diabetes Metab J. 2013;37(1):1\u201321. doi:10.4093\/dmj.2013.37.1.1"},{"issue":"4","key":"B23","series-title":"Rev Bras Anestesiol","first-page":"429","article-title":"Effects of dexmedetomidine on renal system and on vasopressin plasma levels: experimental study in dogs","author":"Villela NR","year":"2005","unstructured":"Villela NR, Nascimento MP, de Carvalho LR, Teixeira VC. Effects of dexmedetomidine on renal system and on vasopressin plasma levels: experimental study in dogs. Rev Bras Anestesiol. 2005;55(4):429\u2013440. doi:10.1590\/s0034-70942005000400007"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/87\/7\/ajvr.25.12.0427.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/87\/7\/ajvr.25.12.0427.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/87\/7\/ajvr.25.12.0427.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:48:29Z","timestamp":1783007309000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/87\/7\/ajvr.25.12.0427.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":46,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.25.12.0427","relation":{},"ISSN":["0002-9645","1943-5681"],"issn-type":[{"value":"0002-9645","type":"print"},{"value":"1943-5681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}